Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]

Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315-1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowledgment sh...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2017-01, Vol.11, p.1567-1568
Hauptverfasser:	Korol, Andrii, Zborovska, Oleksandra, Kustryn, Taras, Dorokhova, Oleksandra, Pasyechnikova, Nataliya
Format:	Artikel
Sprache:	eng
Schlagworte:	Corrigendum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315-1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowledgment should state: The authors take full responsibility for the scope, direction, and content of the manuscript, and have approved the submitted manuscript. Medical writing support was provided by Corey Eagan, MPH, of PAREXEL, and was funded by Bayer Pharmaceuticals.Read the original article
ISSN:	1177-5483 1177-5467 1177-5483
DOI:	10.2147/OPTH.S148326